8 results
8-K
EX-10.1
BLPH
Bellerophon Therapeutics, Inc.
30 Mar 20
Bellerophon Announces $15.3 Million Registered Direct Offering Priced At-the-Market
4:09pm
(or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) when made and on the Closing Date … (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) when made and on the Closing
8-K
EX-1.1
cligy76g
23 Jan 19
Bellerophon Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
5:05pm
S-1
EX-10.14
e3j2v1idovcuolvx8xk9
13 Jan 15
IPO registration
12:00am
- Prev
- 1
- Next